Skip to main content

Table 2 Characteristics of participants (%/mean ± SD)

From: Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study

  Patients with T2D Persons without T2D
n 28 30
Age (years) 63.4 ± 7.8 54.4 ± 10.3
Men (%) 68 47
Diabetes duration (years) 16 ± 8 0
Smokers (%) 21 10
BMI (kg/m2) 32.7 ± 4.5 26.4 ± 3.6
Microalbuminuria (%) 50 0
Prevalent CVD (%) 21 0
Total cholesterol (mmol/l) 3.76 ± 0.71 5.10 ± 1.06
HDL cholesterol (mmol/l) 1.33 ± 0.39 1.55 ± 0.33
LDL cholesterol (mmol/l) 1.76 ± 0.57 2.94 ± 0.93
Triglycerides (mmol/l) 1.45 ± 0.55 1.33 ± 0.57
Treatment with statins (%) 96 10
HbA1c (%) 7.75 ± 1.04 5.52 ± 0.22
Therapeutic methods for T2D:
Diet only/OAD/insulin/OAD+insulin (%)
11/14/50/25  
Systolic blood pressure (mmHg) 132 ± 19 126 ± 13
Diastolic blood pressure (mmHg) 77 ± 9 77 ± 8
Antihypertensive treatment (%) 96 7
Therapeutic method for hypertension:
ACEi/ARB/β-blockers/diuretics/CCB (%)
39/54/11/68/32 0/3/0/3/0
Mean carotid IMT (mm) 0.800 ± 0.131 0.679 ± 0.105
  1. OAD: Oral antidiabetics, ACEi: angiotensin-converting enzyme inhibitor, ARB: angiotensin II receptor blocker, CCB: calcium channel blocker